WO2006110924A3 - Dietary supplement formulations for improved delivery of coenzyme q10 and methods of administration - Google Patents

Dietary supplement formulations for improved delivery of coenzyme q10 and methods of administration Download PDF

Info

Publication number
WO2006110924A3
WO2006110924A3 PCT/US2006/014416 US2006014416W WO2006110924A3 WO 2006110924 A3 WO2006110924 A3 WO 2006110924A3 US 2006014416 W US2006014416 W US 2006014416W WO 2006110924 A3 WO2006110924 A3 WO 2006110924A3
Authority
WO
WIPO (PCT)
Prior art keywords
dietary supplement
coenzyme
administration
methods
improved delivery
Prior art date
Application number
PCT/US2006/014416
Other languages
French (fr)
Other versions
WO2006110924A2 (en
Inventor
Jarrow L Rogovin
Siddharth Shastri
Original Assignee
Jarrow Formulas Inc
Jarrow L Rogovin
Siddharth Shastri
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jarrow Formulas Inc, Jarrow L Rogovin, Siddharth Shastri filed Critical Jarrow Formulas Inc
Priority to CA002604952A priority Critical patent/CA2604952A1/en
Priority to EP06758378A priority patent/EP1940455A4/en
Priority to AU2006235633A priority patent/AU2006235633A1/en
Publication of WO2006110924A2 publication Critical patent/WO2006110924A2/en
Publication of WO2006110924A3 publication Critical patent/WO2006110924A3/en
Priority to AU2011200677A priority patent/AU2011200677B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Abstract

A dietary supplement comprising Coenzyme QlO (i.e. ubiquinone) and a bioadhesive substance is described. Derivatives of Coenzyme QlO may also be used in the dietary supplement. The dietary supplement may be provided to an individual to increase blood plasma levels of Coenzyme QlO.
PCT/US2006/014416 2005-04-14 2006-04-14 Dietary supplement formulations for improved delivery of coenzyme q10 and methods of administration WO2006110924A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002604952A CA2604952A1 (en) 2005-04-14 2006-04-14 Dietary supplement formulations for improved delivery of coenzyme q10 and methods of administration
EP06758378A EP1940455A4 (en) 2005-04-14 2006-04-14 Dietary supplement formulations for improved delivery of coenzyme q10 and methods of administration
AU2006235633A AU2006235633A1 (en) 2005-04-14 2006-04-14 Dietary supplement formulations for improved delivery of coenzyme Q10 and methods of administration
AU2011200677A AU2011200677B2 (en) 2005-04-14 2011-02-17 Dietary supplement formulations for improved delivery of coenzyme Q10 and methods of administration

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67104005P 2005-04-14 2005-04-14
US60/671,040 2005-04-14

Publications (2)

Publication Number Publication Date
WO2006110924A2 WO2006110924A2 (en) 2006-10-19
WO2006110924A3 true WO2006110924A3 (en) 2009-04-16

Family

ID=37087713

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/014416 WO2006110924A2 (en) 2005-04-14 2006-04-14 Dietary supplement formulations for improved delivery of coenzyme q10 and methods of administration

Country Status (5)

Country Link
EP (1) EP1940455A4 (en)
CN (1) CN101500599A (en)
AU (2) AU2006235633A1 (en)
CA (1) CA2604952A1 (en)
WO (1) WO2006110924A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI22465B (en) * 2007-03-15 2010-10-29 Valens Int. D.O.O. New combination of water soluble forms of coenzyme q10 and l-carnitin, procedure of preparation and application
CN101480381B (en) * 2009-01-21 2013-01-02 郑微 Coenzyme Q10 pharmaceutical composition
CN102793167B (en) * 2012-08-17 2014-06-11 福州复美达生物科技有限公司 Rosemary antioxidant coenzyme Q10 capsule and preparation method thereof
CN105561329A (en) * 2016-01-22 2016-05-11 辽宁万嘉医药科技有限公司 Cyclodextrin triad-supramolecular inclusion compound compounded by water-soluble coenzymes Q10 and alpha-lipoic acid and preparing method

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891469A (en) * 1997-04-02 1999-04-06 Pharmos Corporation Solid Coprecipitates for enhanced bioavailability of lipophilic substances
US6045826A (en) * 1999-04-02 2000-04-04 National Research Council Of Canada Water-soluble compositions of bioactive lipophilic compounds
US6403116B1 (en) * 2000-11-03 2002-06-11 Triarco Inductries, Inc. Coenzyme Q10 formulation
US20020071868A1 (en) * 1998-04-29 2002-06-13 Univera Pharmaceuticals, Inc. Multicomponent biological vehicle
US6411050B1 (en) * 1997-12-04 2002-06-25 Namika Precision Jewel Co., Ltd. Device for driving vibration actuator
US20030072798A1 (en) * 2000-01-13 2003-04-17 Alpharx Inc. Solid self-emulsifying dosage form for improved delivery of poorly soluble hydrophobic compounds and the process for preparation thereof
US6652891B2 (en) * 2001-12-12 2003-11-25 Herbasway Laboratories, Llc Co-enzyme Q10 dietary supplement

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1191608B (en) * 1985-02-01 1988-03-23 Zambon Spa PHARMACEUTICAL COMPOSITION AND PHARMACEUTICAL FORMS THAT CONTAIN IT
IL117773A (en) * 1996-04-02 2000-10-31 Pharmos Ltd Solid lipid compositions of coenzyme Q10 for enhanced oral bioavailability
DE10064219B9 (en) * 2000-12-22 2009-02-12 Nasalis Pain Relief International Gmbh Novel pharmaceutical composition containing fentanyl and / or its derivatives

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891469A (en) * 1997-04-02 1999-04-06 Pharmos Corporation Solid Coprecipitates for enhanced bioavailability of lipophilic substances
US6411050B1 (en) * 1997-12-04 2002-06-25 Namika Precision Jewel Co., Ltd. Device for driving vibration actuator
US20020071868A1 (en) * 1998-04-29 2002-06-13 Univera Pharmaceuticals, Inc. Multicomponent biological vehicle
US6045826A (en) * 1999-04-02 2000-04-04 National Research Council Of Canada Water-soluble compositions of bioactive lipophilic compounds
US20030072798A1 (en) * 2000-01-13 2003-04-17 Alpharx Inc. Solid self-emulsifying dosage form for improved delivery of poorly soluble hydrophobic compounds and the process for preparation thereof
US6403116B1 (en) * 2000-11-03 2002-06-11 Triarco Inductries, Inc. Coenzyme Q10 formulation
US6652891B2 (en) * 2001-12-12 2003-11-25 Herbasway Laboratories, Llc Co-enzyme Q10 dietary supplement

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1940455A4 *

Also Published As

Publication number Publication date
AU2006235633A1 (en) 2006-10-19
WO2006110924A2 (en) 2006-10-19
EP1940455A2 (en) 2008-07-09
CN101500599A (en) 2009-08-05
AU2011200677A1 (en) 2011-03-17
EP1940455A4 (en) 2011-01-26
CA2604952A1 (en) 2006-10-19
AU2011200677B2 (en) 2012-08-16

Similar Documents

Publication Publication Date Title
EP1589947B8 (en) Pharmaceutical formulation with an insoluble active agent for pulmonary administration
WO2007047948A3 (en) Intranasal administration of rapid acting insulin
WO2008063211A3 (en) Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
WO2005065319A3 (en) Generally linear effervescent oral fentanyl dosage form and methods of administering
WO2007117509A3 (en) High delivery rates for lipid based drug formulations, and methods of treatment thereof
EP4245299A3 (en) Pharmaceutical formulations containing dapagliflozin propylene glycol hydrate
WO2005112633A3 (en) Compounds and compositions for delivering active agents
WO2009002867A3 (en) Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
WO2007142810A3 (en) Methods of using low-dose doxepin for the improvement of sleep
MXPA05008138A (en) Oral compositions of fenretinide having increased bioavailability and methods of using the same.
WO2004032866A3 (en) Therapeutic formulations
CY1108314T1 (en) ORAL ADMINISTRATION PREPARING FOR HEALTH ACTIVITY ON THE HEALTHCARE SYSTEM
WO2006110924A3 (en) Dietary supplement formulations for improved delivery of coenzyme q10 and methods of administration
WO2005107753A3 (en) Naltrexone long acting formulations and methods of use
WO2008128191A3 (en) Oral cephalotaxine dosage forms
WO2005120518A3 (en) Use of atp analogues for treatment of cardiovascular diseases
WO2003092655A3 (en) Use of active ingredient mixtures with azelaic acids and glycyrrhetic acids as anti-acne agents
WO2009091605A3 (en) Taste titration therapies
WO2005065429A3 (en) Composition and method for treatment of hepatic encephalopathy
TW200420304A (en) Orally administrable pharmaceutical compositions and methods for preventing food-drug interaction
WO2005065640A8 (en) Compositions of buccal dosage forms for extended drug release and the process of preparing such compositions
AU2003246566A1 (en) Administration form for the oral administration of active substances, vitamins, and/or nutrients
MY146102A (en) New citrate salt of an indole derivative and its pharmaceutical use
WO2012058276A3 (en) Methods and materials for reducing mutiple risk factors associated with the metabolic syndrom
TW200722076A (en) Composition for increasing anti-oxidation activity in blood

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200680017516.0

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2604952

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2006235633

Country of ref document: AU

Ref document number: 2006758378

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU